18
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Application of Long-Term Bone Marrow Cultures for Studying the Leukemic Transformation of Myelodysplastic Syndromes

&
Pages 345-352 | Received 06 Mar 1993, Published online: 01 Jul 2009

References

  • Jacobs R. H., Combleet M. A., Vardiman J. W., et al. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765–1772
  • Gyger M., Infante-Rivard C, D'Angelo G., et al. Prognostic value of clonal chromosomal abnormalities in patients with Primary myelodysplastic syndromes. Am. J. Hae-matol. 1988; 28: 13–20
  • Yunis J. J., Rydell R. E., Oken M. M., et al. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1988; 67: 1721–1730
  • Horiike S., Taniwaki M., Misawa S., Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988; 62: 1129–1138
  • Tricot G., Boogaerts M. A., De Wolf-Peeters C., et al. The myelodysplastic syndromes different evolution patterns based on sequential morphological and cytogenetic investigations. Br. J. Haematol. 1985; 59: 659–670
  • Benitez J., Carbonell R., Fayos J. S., et al. Karyotypic evolution in patients with myelodysplastic syndromes. Cancer Genet. Cytogenet. 1985; 16: 157–167
  • Heim S., Mitelman F. Chromosome abnormalities in the myelodysplastic syndromes. Clin. Haematol. 1986; 15: 1003–1022
  • Radua R. A., Carter G., Hughes D., et al. RAS mutations in myelodysplesia detected by amplification, oligonucleotide hybridization and transformation. Leukemia 1988; 2: 503–510
  • Mecucci C, Rege-Cambrin G., Michaux J. L., et al. Multiple chromosome distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the diseases. Br. J. Haematol. 1986; 64: 699–706
  • Sutherland H. J., Eaves C. J., Eaves A. C., et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563–1570
  • Tamura S., Kanamaru A., Kakishita E., Nagai K. Detection of latent subclones with abnormal karyotypes by long-term bone marrow cultures in cases of myelodysplastic syndrome. Br. J. Haematol. 1992; 81: 353–361
  • Dexter T. M., Allen T. D., Lajtha L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol. 1977; 91: 335–344
  • Bynoe A. G., Scott C. S., Ford P., et al. Decreased T-helper cells in the myelodysplastic syndrome. Blood 1983; 61: 449–455
  • Janssen J. W. G., Buschle M., Layton M., et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989; 73: 248–254
  • Kibbelaar R. E., van Kamp H., Dreef E. J., et al. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood 1992; 79: 1823–1828
  • Culligan D. J., Cathia P., Whittaker J., et al. Clonal lymphocytes are detectable in only some cases of MDS. Br. J. Haematol. 1992; 81: 346–352
  • Van Kamp H., Fibbc W. E., Jansen P. M., et al. Clonal involvement of granulocyte and monocytes, but not of T and B lymphocytes and natural killes cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymorase chain reaction of the phos-phoglycerate kinase gene. Blood 1992; 80: 1774–1780
  • Gaddes A. D., Bowen D. T., Jacobs. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome. Br. J. Haematol. 1990; 76: 194–202
  • Tamura S., Kanamaru A., Takemoto Y., et al. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukemia with trilineage myelodysplasia and with myelodysplastic remission marrow. Br. J. Haematol. 1993, in press
  • Brito-Babapulle F., Catovsky D., Galton D. A. G. Clinical and laboratory features of trilineage myelodysplasia. Br. J. Haematol. 1987; 66: 445–450
  • Jacobs A., Culligan D. Myelodysplasia and pre-leukemia: pathogenesis and functional aspects. Leukemia, J. A. Whittaker. Blackwell Scientific Publications, Oxford 1992; 227
  • Besa E. C. Myelodysplastic syndromes (refractory anemia) A perspective of the biologic, clinical, and therapeutic issues. Med. Clin. N. Am. 1992; 76: 599–617
  • Fearon E. R., Vogelestein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–767
  • Hirai H., Kobayashi Y., Mano H., et al. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987; 327: 430–432
  • Yunis J. J., Boot A. J. M., Mayer M. G., Bos J. L. Mechanisms of ras mutation in myelodysplastic syndrome. Oncogene 1989; 4: 609–614
  • Ahuja H. G., Foti A., Bar-Eli M., Cline M. J. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684–1690
  • Jonveaux P. H., Fenaux P., Quiquandon I., et al. Mutations in the p53 gene in myelodysplastic syndromes. Oncogene 1991; 6: 2243
  • Ridge S. A., Worwood M., Oscier D., et al. FMS mutations in myelodysplastic, leukemic and normal subjects. Proc. Natl. Acad. Sci. USA 1990; 87: 1377–1386

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.